Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
FASEB J ; 26(8): 3537-49, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22573912

RESUMO

Energy production in mitochondria is a multistep process that requires coordination of several subsystems. While reversible phosphorylation is emerging as the principal tool, it is still unclear how this signal network senses the workloads of processes as different as fuel procurement, catabolism in the Krebs cycle, and stepwise oxidation of reducing equivalents in the electron transfer chain. We previously proposed that mitochondria use oxidized cytochrome c in concert with retinol to activate protein kinase Cδ, thereby linking a prominent kinase network to the redox balance of the ETC. Here, we show that activation of PKCε in mitochondria also requires retinol as a cofactor, implying a redox-mechanism. Whereas activated PKCδ transmits a stimulatory signal to the pyruvate dehdyrogenase complex (PDHC), PKCε opposes this signal and inhibits the PDHC. Our results suggest that the balance between PKCδ and ε is of paramount importance not only for flux of fuel entering the Krebs cycle but for overall energy homeostasis. We observed that the synthetic retinoid fenretinide substituted for the retinol cofactor function but, on chronic use, distorted this signal balance, leading to predominance of PKCε over PKCδ. The suppression of the PDHC might explain the proapoptotic effect of fenretinide on tumor cells, as well as the diminished adiposity observed in experimental animals and humans. Furthermore, a disturbed balance between PKCδ and PKCε might underlie the injury inflicted on the ischemic myocardium during reperfusion. dehydrogenase complex.


Assuntos
Metabolismo Energético/efeitos dos fármacos , Homeostase/efeitos dos fármacos , Proteína Quinase C-delta/metabolismo , Proteína Quinase C-épsilon/metabolismo , Complexo Piruvato Desidrogenase/metabolismo , Animais , Linhagem Celular , Ciclo do Ácido Cítrico , Ativação Enzimática , Fenretinida/farmacologia , Camundongos , Mitocôndrias Hepáticas/efeitos dos fármacos , Mitocôndrias Hepáticas/metabolismo , Fosforilação Oxidativa/efeitos dos fármacos , Fosforilação , Proteína Quinase C-delta/efeitos dos fármacos , Proteína Quinase C-épsilon/genética , Complexo Piruvato Desidrogenase/antagonistas & inibidores , Transdução de Sinais/efeitos dos fármacos , Vitamina A/metabolismo , Dedos de Zinco
2.
PLoS One ; 6(10): e24634, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22016761

RESUMO

Obesity is a major and independent risk factor for cardiovascular disease and it is strongly associated with the development of dyslipidemia, insulin resistance and type 2 diabetes. Flavonoids, a diverse group of polyphenol compounds of plant origin widely distributed in human diet, have been reported to have numerous health benefits, although the mechanisms underlying these effects have remained obscure. We analyzed the effects of chronic dietary supplementation with flavonoids extracted from cranberry (FLS) in normal and obese C57/BL6 mice compared to mice maintained on the same diets lacking FLS. Obese mice supplemented with flavonoids showed an amelioration of insulin resistance and plasma lipid profile, and a reduction of visceral fat mass. We provide evidence that the adiponectin-AMPK pathway is the main mediator of the improvement of these metabolic disorders. In contrast, the reduced plasma atherogenic cholesterol observed in normal mice under FLS seems to be due to a downregulation of the hepatic cholesterol synthesis pathway. Overall, we demonstrate for the first time that the molecular mechanisms underlying the beneficial effects of flavonoids are determined by the metabolic state.


Assuntos
Aterosclerose/tratamento farmacológico , Flavonoides/farmacologia , Obesidade/tratamento farmacológico , Proteínas Quinases Ativadas por AMP/metabolismo , Adiponectina/sangue , Adiponectina/metabolismo , Animais , Glicemia/metabolismo , Peso Corporal/efeitos dos fármacos , Colesterol/biossíntese , Colesterol/sangue , Regulação para Baixo/efeitos dos fármacos , Flavonoides/isolamento & purificação , Flavonoides/uso terapêutico , Saúde , Humanos , Gordura Intra-Abdominal/efeitos dos fármacos , Gordura Intra-Abdominal/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Obesos , Músculos/efeitos dos fármacos , Músculos/metabolismo , Obesidade/sangue , Obesidade/metabolismo , Obesidade/patologia , Tamanho do Órgão/efeitos dos fármacos , Fosforilação/efeitos dos fármacos , Receptores de Adiponectina/genética , Receptores de Adiponectina/metabolismo , Transdução de Sinais/efeitos dos fármacos , Vaccinium macrocarpon/química
3.
Clin Biochem ; 43(3): 320-3, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19857477

RESUMO

OBJECTIVES: To evaluate whether serum RBP4 correlates with gestational diabetes mellitus (GDM) in a cohort of borderline obese (BMI>30) pregnant women. DESIGN AND METHODS: Serum RBP4 and retinol were measured in pregnant women with (n=12) and without (n=10) GDM. RESULTS: RBP4, retinol and RBP4:retinol molar ratio were not different between the groups and were not associated with markers of insulin resistance. CONCLUSIONS: GDM is not associated with RBP4 or retinol among borderline obese pregnant women.


Assuntos
Diabetes Gestacional/sangue , Obesidade/sangue , Proteínas Plasmáticas de Ligação ao Retinol/metabolismo , Vitamina A/sangue , Adulto , Animais , Glicemia/metabolismo , Feminino , Humanos , Insulina/sangue , Leptina/sangue , Gravidez , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA